New Fully Automated Preparation of High Apparent Molar Activity <sup>68</sup>Ga-FAPI-46 on a Trasis AiO Platform

A large number of applications for fibroblast activation protein inhibitors (FAPI)-based PET agents have been evaluated in conditions ranging from cancer to non-malignant diseases such as myocardial infarction. In particular, <sup>68</sup>Ga-FAPI-46 was reported to have a high specificit...

Full description

Bibliographic Details
Published in:	Molecules
Main Authors:	Chiara Da Pieve, Marta Costa Braga, David R. Turton, Frank A. Valla, Pinar Cakmak, Karl-Heinz Plate, Gabriela Kramer-Marek
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Subjects:	FAP gallium-68 FAPI-46 automated radiosynthesis Trasis AiO preclinical PET
Online Access:	https://www.mdpi.com/1420-3049/27/3/675

Similar Items

Automated synthesis of [68Ga]Ga-FAPI-46 without pre-purification of the generator eluate on three common synthesis modules and two generator types
by: Ammar Alfteimi, et al.
Published: (2022-07-01)

Preclinical evaluation of [68Ga]Ga-AAZTA-FAPI-46: a novel PET tracer for targeting fibroblast activation protein (FAP)
by: Rebecca Rizzo, et al.
Published: (2025-08-01)

Development of a versatile [68Ga]Ga-FAPI-46 automated synthesis suitable to multi-elutions of germanium-68/gallium-68 generators
by: Louis-Paul Paty, et al.
Published: (2024-07-01)

Fully-automated production of [68Ga]Ga-FAPI-46 for clinical application
by: Sarah Spreckelmeyer, et al.
Published: (2020-12-01)

Production and Quality Control of [<sup>68</sup>Ga]Ga-FAPI-46: Development of an Investigational Medicinal Product Dossier for a Bicentric Clinical Trial
by: Alessandro Cafaro, et al.
Published: (2025-09-01)

Molecular Imaging of Fibroblast Activation Protein in Response to Cardiac Injury Using [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.FAPi
by: Victoria Weissenböck, et al.
Published: (2025-04-01)

From Automated Synthesis to In Vivo Application in Multiple Types of Cancer—Clinical Results with [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.FAPi
by: Lukas Greifenstein, et al.
Published: (2022-08-01)

Automated Synthesis of [<sup>68</sup>Ga]Ga-FAPI-46 on a Scintomics GRP Synthesizer
by: Elisabeth Plhak, et al.
Published: (2023-08-01)

Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the <sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)<sub>2</sub>
by: Tilman Läppchen, et al.
Published: (2024-06-01)

PET/CT WITH 68GA-FAPI46 FOR THE DETECTION OF PRIMARY AND METASTATIC LESIONS IN PATIENTS WITH DIFFERENT TYPES OF CANCER. INITIAL EXPERIENCE
by: Lilian Yuri Itaya Yamaga, et al.
Published: (2025-05-01)

The synergy of 177Lu-FAPI-46 with tyrosine kinase inhibitor in a sarcoma patient-derived xenograft mouse model
by: Jing-Ren Tseng, et al.
Published: (2024-06-01)

Fully automated radiosynthesis of [68Ga]Ga-FAPI-46 with cyclotron produced gallium
by: Adam J. Rosenberg, et al.
Published: (2023-10-01)

Novel <sup>68</sup>Ga-Labeled Pyridine-Based Fibroblast Activation Protein-Targeted Tracers with High Tumor-to-Background Contrast
by: Arsyangela Verena, et al.
Published: (2023-03-01)

AUTOMATED SYNTHESIS AND IN VITRO STUDIES OF [68GA]GA-FAPI-46 IN HOSPITAL RADIOPHARMACY
by: Leonardo Lima Fuscaldi, et al.
Published: (2024-04-01)

<sup>68</sup>Ga Extemporaneous Preparations in Radiopharmacy
by: Marzia Rizzello, et al.
Published: (2025-06-01)

Recent implications of FAPI PET in cardiac diseases
by: Lan Wang, et al.
Published: (2025-10-01)

Synthesis and Preliminary Evaluation of FAPα Targeted Tracer 131I-FAPI-03
by: MA Huan1, 2, LIAO Jiali2, YANG Yuanyou2, LIU Ning2, LI Feize2
Published: (2024-04-01)

<sup>68</sup>Ga-DOTA-D-Alanine-BoroPro Radiotracer for Imaging of the Fibroblast Activation Protein in Malignant and Non-Malignant Diseases
by: Diana Trujillo-Benítez, et al.
Published: (2024-04-01)

Synthesis and Evaluation of <sup>68</sup>Ga-Labeled (2<i>S</i>,4<i>S</i>)-4-Fluoropyrrolidine-2-Carbonitrile and (4<i>R</i>)-Thiazolidine-4-Carbonitrile Derivatives as Novel Fibroblast Activation Protein-Targeted PET Tracers for Cancer Imaging
by: Shreya Bendre, et al.
Published: (2023-04-01)

Fully Automated Macro- and Microfluidic Production of [<sup>68</sup>Ga]Ga-Citrate on mAIO<sup>®</sup> and iMiDEV<sup>TM</sup> Modules
by: Olga Ovdiichuk, et al.
Published: (2022-02-01)

Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trial
by: Morten Bentestuen, et al.
Published: (2024-06-01)

Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer
by: Simone Wegen, et al.
Published: (2024-04-01)

Clinically Applicable Cyclotron-Produced Gallium-68 Gives High-Yield Radiolabeling of DOTA-Based Tracers
by: Emma Jussing, et al.
Published: (2021-07-01)

FAPI PET/CT Imaging—An Updated Review
by: Kunal Ramesh Chandekar, et al.
Published: (2023-06-01)

Towards a General Method for Using Cyclotron-Produced Ga68 to Manufacture Clinical and Research Ga68 Tracers
by: Ivan E. Wang, et al.
Published: (2024-11-01)

Modyfikacje algorytmów planowania trasy uwzględniające ograniczenia czasowe i odległoĞciowe
by: Mateusz Wolanin, et al.
Published: (2019-03-01)

Synthesis and Preclinical Evaluation of Novel <sup>68</sup>Ga-Labeled (<i>R</i>)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging
by: Shreya Bendre, et al.
Published: (2023-05-01)

Comparative diagnostic performance of [68Ga]Ga-FAPI-46 and [18F]FDG PET/CT imaging for the detection of active lesions and disease stage evaluation in breast cancer patients
by: Kiana Radmehr, et al.
Published: (2025-01-01)

Rapid Concentration of Ga-68 and Proof-of-Concept Microscale Labeling of [<sup>68</sup>Ga]Ga-PSMA-11 in a Droplet Reactor
by: Yingqing Lu, et al.
Published: (2024-09-01)

Zastosowanie grafu widoczności w planowaniu trasy przejścia statku
by: A. Lazarowska
Published: (2017-10-01)

[<sup>68</sup>Ga]Ga-DOTAGA-Glu(FAPi)<sub>2</sub> Shows Enhanced Tumor Uptake and Theranostic Potential in Preclinical PET Imaging
by: Julie van Krimpen Mortensen, et al.
Published: (2024-09-01)

Comparison of <sup>18</sup>F-FDG PET/CT and <sup>68</sup>Ga-FAPI in Spindle Cell Rhabdomyosarcoma
by: Zhihui Shen, et al.
Published: (2023-09-01)

In Vivo Fibroblast Activation of Systemic Sarcoidosis: A <sup>68</sup>Ga-FAPI-04 PET/CT Imaging Study
by: Jingnan Wang, et al.
Published: (2023-04-01)

Development of a Synthetic Method for [68Ga]Ga-FAPI-04 Using a Cassette-based Synthesizer
by: Jun Young PARK, et al.
Published: (2024-03-01)

Fully Automated Production of (((<i>S</i>)-1-Carboxy-5-(6-([<sup>18</sup>F]fluoro)-2-methoxynicotinamido)pentyl)carbamoyl)-<span style="font-variant: small-caps">l</span>-glutamic Acid ([<sup>18</sup>F]JK-PSMA-7)
by: Philipp Krapf, et al.
Published: (2025-01-01)

First Clinical Experience of <sup>68</sup>Ga-FAPI PET/CT in Tertiary Cancer Center: Identifying Pearls and Pitfalls
by: Akram Al-Ibraheem, et al.
Published: (2025-01-01)

Compact and cGMP-compliant automated synthesis of [18F]FSPG on the Trasis AllinOne™
by: Rizwan Farooq, et al.
Published: (2025-01-01)

[<sup>68</sup>Ga]Ga-FAP-2286—Synthesis, Quality Control and Comparison with [<sup>18</sup>F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma
by: Anton Amadeus Hörmann, et al.
Published: (2024-08-01)

Microfluidic-based production of [68Ga]Ga-FAPI-46 and [68Ga]Ga-DOTA-TOC using the cassette-based iMiDEV™ microfluidic radiosynthesizer
by: Hemantha Mallapura, et al.
Published: (2023-12-01)

68Ga-FAPI-04 Versus 18F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
by: Hao Wang, et al.
Published: (2021-06-01)